For years, I’ve watched promising medical applied sciences languish in labs, by no means reaching the sufferers who desperately want them. The offender? Not overzealous regulators, however our outdated method to innovation. It’s time to cease pointing fingers on the FDA and take a superb arduous look within the mirror.

The reality is, the FDA will not be the enemy of medical innovation—it’s a important associate. However to unlock its full potential as an ally, we have to radically rethink how we develop medical gadgets. The present mannequin of siloed, proprietary growth is failing us. It’s gradual, costly, and infrequently leads to applied sciences that by no means see the sunshine of day.

What if we as a substitute embraced an open-source method to medical gadget innovation?

As an alternative of every firm growing gadgets individually, what if we created open, modular platforms that hundreds may construct on? Security knowledge could possibly be shared between functions, dramatically decreasing the time and value of regulatory approvals. Manufacturing may leverage current shopper electronics provide chains, dramatically decreasing manufacturing prices.

This isn’t circumventing FDA necessities, nevertheless it does give them extra knowledge to work with. By enabling hundreds of parallel improvements and trials, we may generate orders of magnitude extra knowledge than the standard mannequin. This wealth of data would enable regulators to make sooner, extra knowledgeable selections.

The FDA has proven openness to new approaches, from breakthrough gadget designation to real-world proof applications. What is required now’s for us, the innovators, to give you new fashions that work throughout the regulatory framework to speed up growth.

An open-source method may minimize gadget growth timelines from 13 years to three years and prices from $650 million to $10 million. Extra importantly, it may lastly deliver groundbreaking medical expertise to the billions who at present don’t have entry to it.

However to make this imaginative and prescient a actuality, we should overcome our resistance to alter. We should let go of the concept that locking up our improvements is the one technique to shield their worth. Within the open supply world, worth will not be created by hoarding data, however by constructing on shared information to create one thing really life-changing.

This shift is not going to be simple. It should require a elementary change in how we take into consideration mental property, competitors and collaboration. However the potential rewards are immense. By pooling our sources and experience, we are able to sort out essentially the most difficult medical issues of our time with unprecedented velocity and effectivity.

The challenges in our healthcare system are advanced, with no simple options. However by reimagining how we develop and approve medical gadgets, we’ve got a chance to dramatically speed up innovation. It’s time to maneuver past finger-pointing and embrace a collaborative mannequin that works for innovators, regulators, and sufferers.

The expertise to avoid wasting hundreds of thousands of lives exists as we speak. It’s not being captured by overzealous regulators, however by our personal outdated mindsets and enterprise fashions. Let’s break by these self-imposed limitations and usher in a brand new period of medical innovation.

The FDA is ready for us to behave. I’m able to tear down the partitions I’ve constructed round my work. Are you?

Picture: Peshkova, Getty Pictures

Mary Lou Jepsen, PhD is the founder, CEO, and chairman of Openwater.well being, a medical expertise firm that integrates semiconductor physics, mild, and sound to diagnose and deal with illnesses on the mobile degree. Openwater strives to make hospital-quality medical care accessible worldwide. The corporate's platform combines infrared imaging, ultrasound, and electromagnetic fields. Openwater collaborates with main establishments to validate its expertise and drive innovation in healthcare. Utilizing open-source ideas and shopper electronics manufacturing, Openwater goals to cut back the event time and value of medical gadgets. Jepsen has been named to Time Journal's 100 Most Influential Individuals and CNN's High 10 Thinkers. Jepsen is a former government at Fb, Oculus, Google, and Intel, and based 4 {hardware} corporations, together with One Laptop computer per Youngster (OLPC). Jepsen is a former MIT professor with 250 printed or issued patents.

This message seems through the MedCity influencers program. Anybody can publish their perspective on healthcare points and innovation on MedCity Information through MedCity Influencers. Click on right here to learn the way.